| P50 | author | Zhiren Zhang | Q56027888 |
| P2093 | author name string | Yu Liu | |
| | Jinsong Wang | |
| | Yuzhang Wu | |
| | Zigang Shen | |
| | Yu-Qi Liu | |
| | Man Jiang | |
| | Zongwei Liu | |
| | Bangwei Luo | |
| | Rongchen Shi | |
| P2860 | cites work | A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation | Q24294741 |
| | Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals | Q24673096 |
| | The pleiotropic effects of erythropoietin in infection and inflammation | Q26864149 |
| | The erythropoietin receptor and its expression in tumor cells and other tissues | Q28297838 |
| | Resolution of acute inflammation in the lung | Q28652204 |
| | Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators | Q29615694 |
| | Resolution of inflammation: the beginning programs the end | Q29615695 |
| | Nonresolving inflammation | Q29616352 |
| | HIF-1alpha is essential for myeloid cell-mediated inflammation | Q29617581 |
| | Resolvin E1 and protectin D1 activate inflammation-resolution programmes | Q29618679 |
| | Activation of the neutrophil respiratory burst oxidase | Q30175836 |
| | Pro-resolving lipid mediators are leads for resolution physiology | Q30829097 |
| | Clinical aspects of chronic granulomatous disease | Q31804597 |
| | Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens | Q33996240 |
| | Inflammation 2010: new adventures of an old flame | Q34105595 |
| | The resolution of inflammation: the devil in the flask and in the details | Q34181437 |
| | Macrophages as novel target cells for erythropoietin | Q34255067 |
| | Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury | Q34265287 |
| | PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease | Q34374048 |
| | Proresolving lipid mediators and mechanisms in the resolution of acute inflammation | Q34411426 |
| | Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways | Q34544348 |
| | Hypoxia-inducible factor α subunit stabilization by NEDD8 conjugation is reactive oxygen species-dependent | Q34606086 |
| | Nitric oxide prevents axonal degeneration by inducing HIF-1-dependent expression of erythropoietin | Q34720972 |
| | Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis | Q34752092 |
| | Macrophage signaling and respiratory burst | Q34981891 |
| | Hypoxia-inducible factors as essential regulators of inflammation | Q35130618 |
| | Inflammation and repeated infections in CGD: two sides of a coin | Q35644145 |
| | The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems | Q35828194 |
| | Erythropoietin as an antiapoptotic, tissue-protective cytokine. | Q35831214 |
| | Emerging biological roles for erythropoietin in the nervous system | Q36146959 |
| | Role of erythropoietin in the brain | Q36153802 |
| | Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA | Q36210558 |
| | Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion | Q36326008 |
| | Macrophage peroxisome proliferator-activated receptor γ deficiency delays skin wound healing through impairing apoptotic cell clearance in mice | Q36347076 |
| | Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing | Q36376065 |
| | NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis. | Q36382191 |
| | Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration | Q36603509 |
| | Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies | Q36740470 |
| | An efferocytosis-induced, IL-4-dependent macrophage-iNKT cell circuit suppresses sterile inflammation and is defective in murine CGD | Q36797270 |
| | Erythropoietin in cancer patients | Q37315964 |
| | Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators | Q37465090 |
| | Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. | Q37470344 |
| | Targeting the hypoxia-inducible factor (HIF) pathway in cancer. | Q37587446 |
| | Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation | Q37633213 |
| | Hypoxia and inflammation | Q37842498 |
| | The potential role of erythropoietin as a pleiotropic agent in post-cardiac arrest syndrome | Q37864344 |
| | Erythropoietin, erythropoiesis and beyond | Q37904170 |
| | Erythropoietin and the heart: physiological effects and the therapeutic perspective | Q38174673 |
| | Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance. | Q38794549 |
| | Erythropoietin upregulates the expression of its own receptor in TF-1 cell line | Q41041874 |
| | Erythropoietin administration suppresses human monocyte function in vitro and during therapy-induced anemia in HCV patients | Q42991174 |
| | A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties | Q43209045 |
| | Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. | Q46175545 |
| | Molecular circuits of resolution: formation and actions of resolvins and protectins | Q46391207 |
| | Correction of deficient phagocytosis during erythropoietin treatment in maintenance hemodialysis patients | Q49119276 |
| | Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis. | Q51056429 |
| | Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide | Q68255434 |
| | Chronic granulomatous disease | Q84018615 |
| | Erythropoietin | Q86260187 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| | macrophage | Q184204 |
| | erythropoietin | Q218706 |
| P304 | page(s) | 12177 | |
| P577 | publication date | 2016-07-11 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution | |
| P478 | volume | 7 | |